Skip to main content
⌘K
·
Launch Terminal
Home
More
Screener
RNLXY
SEC Filings
Home
More
Screener
RNLXY
SEC Filings
Renalytix plc (RNLXY)
Sector: Services-Medical Laboratories
OTC:RNLXY
OTC:RNLXY
Mkt Cap
-
EV
-
Float
-
Shares O/S
-
Inst Own
-
Net Cash/Sh
-
Dilution
+2.70%
$3.80
Mkt Cap
-
EV
-
Float
-
O/S
-
Inst Own
-
Net Cash/Sh
-
Dilution
OTC:RNLXY
$3.80
+2.70%
MCap
-
Float
-
O/S
-
Inst Own
-
Dilution
Overview
Overview
Dilution
Dilution
Financials
Financials
SEC Filings
SEC Filings
Press Releases
Press
Shorts
Shorts
Clinical Trials
Trials
Open on Terminal
Any time
30D
90D
1Y
3Y
Custom
8-K
8-K/A
10-K
10-K/A
10-Q
20-F
20-F/A
6-K
6-K/A
S-3
S-3/A
S-8
F-1
F-1/A
F-3
F-6
DEF 14A
DEFA14A
PRE 14A
3
4
13D
13D/A
13G
13G/A
424B3
424B4
424B5
FWP
NT 10-Q
UPLOAD
CORRESP
RW
Form
Description
Filed
Links
13D/A
Beneficial Ownership Report (Active, Amended)
2/23/26
Feb 23, 2026
F-6 POS
SEC Filing
12/3/25
Dec 3, 2025
F-6 POS
SEC Filing
9/4/25
Sep 4, 2025
EFFECT
Notice of Effectiveness
7/30/25
Jul 30, 2025
EFFECT
Notice of Effectiveness
7/30/25
Jul 30, 2025
EFFECT
Notice of Effectiveness
7/30/25
Jul 30, 2025
EFFECT
Notice of Effectiveness
7/30/25
Jul 30, 2025
EFFECT
Notice of Effectiveness
7/30/25
Jul 30, 2025
424B3
Prospectus
7/30/25
Jul 30, 2025
15-12G
SEC Filing
7/30/25
Jul 30, 2025
POS AM
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3
7/29/25
Jul 29, 2025
POS AM
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3
7/29/25
Jul 29, 2025
POS AM
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3
7/29/25
Jul 29, 2025
POS AM
POST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-3 ON FORM S-3
7/29/25
Jul 29, 2025
POS AM
POST-EFFECTIVE AMENDMENT NO. 3 TO FORM F-3 ON FORM S-3
7/29/25
Jul 29, 2025
S-8 POS
REGISTRATION STATEMENT
7/25/25
Jul 25, 2025
S-8 POS
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8
7/25/25
Jul 25, 2025
13G/A
Beneficial Ownership Report (Amended)
4/30/25
Apr 30, 2025
13G/A
Beneficial Ownership Report (Amended)
4/30/25
Apr 30, 2025
13G
Beneficial Ownership Report
2/10/25
Feb 10, 2025
8-K
CURRENT REPORT
1/16/25
Jan 16, 2025
8-K
CURRENT REPORT
12/20/24
Dec 20, 2024
DEF 14A
PROXY STATEMENT
11/25/24
Nov 25, 2024
8-K/A
AMENDMENT NO. 1 TO FORM 8-K
11/19/24
Nov 19, 2024
10-Q
Quarterly Report
11/19/24
Nov 19, 2024
1-25
of
233
filings
1
2
…
10
1
2
3
4
…
10
Learn
MCP
API
Show Index Strip
Privacy
Legal
Cookies
Cookie Preferences
Renalytix plc (RNLXY) SEC Filings: 10-K, 10-Q, 8-K, Form 4 | Signal8